Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party

The objective of this registry study was to analyse the outcome of patients who underwent allogeneic or autologous haematopoietic stem cell transplantation (HSCT) for hepatosplenic T-cell lymphoma (HSTL), a rare and extremely aggressive peripheral T-cell lymphoma subtype. Patients were eligible if t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tanase, Alina (VerfasserIn) , Dreger, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2015
In: Leukemia
Year: 2014, Jahrgang: 29, Heft: 3, Pages: 686-688
ISSN:1476-5551
DOI:10.1038/leu.2014.280
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/leu.2014.280
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/leu2014280
Volltext
Verfasserangaben:A. Tanase, N. Schmitz, H. Stein, A. Boumendil, H. Finel, L. Castagna, D. Blaise, N. Milpied, G. Sucak, A. Sureda, K. Thomson, E. Vandenberghe, A. Vitek, and P. Dreger

MARC

LEADER 00000caa a2200000 c 4500
001 170283736X
003 DE-627
005 20220818133943.0
007 cr uuu---uuuuu
008 200629r20152014xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2014.280  |2 doi 
035 |a (DE-627)170283736X 
035 |a (DE-599)KXP170283736X 
035 |a (OCoLC)1341341977 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tanase, Alina  |e VerfasserIn  |0 (DE-588)1212801288  |0 (DE-627)1702837343  |4 aut 
245 1 0 |a Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma  |b a retrospective study of the EBMT Lymphoma Working Party  |c A. Tanase, N. Schmitz, H. Stein, A. Boumendil, H. Finel, L. Castagna, D. Blaise, N. Milpied, G. Sucak, A. Sureda, K. Thomson, E. Vandenberghe, A. Vitek, and P. Dreger 
264 1 |c 2015 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 19 September 2014 
500 |a Gesehen am 29.06.2020 
520 |a The objective of this registry study was to analyse the outcome of patients who underwent allogeneic or autologous haematopoietic stem cell transplantation (HSCT) for hepatosplenic T-cell lymphoma (HSTL), a rare and extremely aggressive peripheral T-cell lymphoma subtype. Patients were eligible if they had histologically verified HSTL and underwent HSCT between 2003 and 2011. Seventy-six patients were identified in the European Society for Bone and Marrow Transplantation database. Additional baseline and follow-up information could be obtained from the referring centres for 36 patients. Eleven of these were excluded following histopathology review, leaving 25 patients in the final study cohort (alloHSCT 18, autoHSCT 7). With a median follow-up of 36 months, 2 patients relapsed after alloHSCT, resulting in a 3-year progression-free survival of 48%. After autoHSCT, 5 patients relapsed and subsequently died. This study indicates that graft-versus-lymphoma activity conferred by alloHSCT can result in long-term survival for a substantial proportion of patients with HSTL. 
534 |c 2014 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 29(2015), 3, Seite 686-688  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma a retrospective study of the EBMT Lymphoma Working Party 
773 1 8 |g volume:29  |g year:2015  |g number:3  |g pages:686-688  |g extent:3  |a Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma a retrospective study of the EBMT Lymphoma Working Party 
856 4 0 |u https://doi.org/10.1038/leu.2014.280  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu2014280  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200629 
993 |a Article 
994 |a 2015 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
999 |a KXP-PPN170283736X  |e 3692036086 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"recId":"170283736X","type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"disp":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma a retrospective study of the EBMT Lymphoma Working PartyLeukemia","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"note":["Gesehen am 15.03.04"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"recId":"32046699X","title":[{"title_sort":"Leukemia","title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal"}],"language":["eng"],"part":{"text":"29(2015), 3, Seite 686-688","year":"2015","volume":"29","extent":"3","pages":"686-688","issue":"3"},"pubHistory":["Nachgewiesen 11.1997 -"]}],"note":["Published: 19 September 2014","Gesehen am 29.06.2020"],"physDesc":[{"extent":"3 S."}],"id":{"eki":["170283736X"],"doi":["10.1038/leu.2014.280"]},"name":{"displayForm":["A. Tanase, N. Schmitz, H. Stein, A. Boumendil, H. Finel, L. Castagna, D. Blaise, N. Milpied, G. Sucak, A. Sureda, K. Thomson, E. Vandenberghe, A. Vitek, and P. Dreger"]},"person":[{"given":"Alina","role":"aut","display":"Tanase, Alina","family":"Tanase"},{"role":"aut","given":"Peter","display":"Dreger, Peter","family":"Dreger"}],"language":["eng"],"title":[{"title_sort":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma","subtitle":"a retrospective study of the EBMT Lymphoma Working Party","title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma"}]} 
SRT |a TANASEALINALLOGENEIC2015